Evidencias y estudios científicos
Especialmente dedicado a lo tituleros de bata blanca, algunos con fonendo al cuello, influencer de pacotilla
y a esos ratoncillos que todavía están dando vueltas en la rueda
Ford ES, G. W. (2002). “Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey”. 287 (3):. JAMA, 287(3), 356–359. Retrieved Abr 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/11790215
Garvey WT, O. J. (1986, Mar). Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes., 35(3), 258-67. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/351233
American Diabetes Association. (2013). (A. V. American Diabetes Association – 1701 North Beauregard Street, Producer) Retrieved Oct 26, 2013, from American Diabetes Association: http://www.diabetes.org/espanol/?loc=rednav.
Ford ES, G. W. (2002). “Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey”. 287 (3):. JAMA, 287(3), 356–359. Retrieved Abr 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/11790215
Frassetto LA, S. M.-S. (2009, Aug). Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. European Journal of Clinical Nutrition, 63(8), 947-55. Retrieved 4 28, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/19209185
Garvey WT, O. J. (1986, Mar). Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes., 35(3), 258-67. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/3512337
Kotronen A, J. L.-J. (2008). Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterolog, 135(1):122-30.
O’Keefe JH Jr, C. L. (2004, Jan). Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer. Mayo Clin Proc, 79(1), 101-8. Retrieved Abr 28, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/14708953
O’Keefe JH, G. N. (2008, Jan 22). Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiology, 51(3), 249-55. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18206731 PARKER, B. B. (2002). Effect of a High-Protein, High–Monounsaturated Fat Weight LossDiet on Glycemic Control and Lipid Levels in Type 2 Diabetes. Diabetes Care, 25(3), 425-430. Retrieved from
http://care.diabetesjournals.org/content/25/3/425.full.pdfRochon, I. T. (2003). Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clinical Science, 104(1), 7–15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12519082
Stanická, S. K. (2005). Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clinical Chemistry and Laboratory Medicine, 43(7), 715–720. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/16207130
Yki-Järvinen, H. (2005). Fat in the liver and insulin resistance. Annals of Medicine, 37(5), 347-56. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/16179270
Barnard RJ, et al. (1995). Diet, not aging, causes skeletal muscle insulin resistance. Gerontology., 41(4), 205-11. Retrieved March 17, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/7557497
Barnard RJ, et al. (1998, April 1). Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. Journal of Applied Physiology, 84(4), 1311-1315. Retrieved March 17, 2014, from
http://www.jappl.org/content/84/4/1311.short
Beavers KM, et al. (2013). The Role of Metabolic Syndrome, Adiposity, and Inflammation in Physical Performance in the Health ABC Study. J Gerontol A Biol Sci Med Sci, 68(5), 617-623. doi:10.1093/gerona/gls213
Brand-Miller JC, S. K. (2009, Jan). Glycemic index, postprandial glycemia, and the shape of the curve in healthy subjects: analysis of a database of more than 1,000 foods. Am J Clin Nutr., 89(1), 97-105. doi:10.3945/ajcn.2008.26354
Daly ME, V. C. (1998, Jun). Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr., 67(6), 1186-96. Retrieved April 19, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/9625092
Dekker MJ, et al. (2010). Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab., 299(5), E685-94. doi:10.1152/ajpendo.00283.2010
Forsythe CE, et al. (2008). Comparison of Low Fat and Low Carbohydrate Diets on Circulating Fatty Acid Composition and Markers of Inflammation. Lipids, 43, 65-77. doi:10.1007/s11745-007-3132-7
Goran MI, et al. (2013). High fructose corn syrup and diabetes prevalence: a global perspective. Glob Public Health., 8(1), 55- 64. doi:10.1080/17441692.2012.736257
Mäkimattila S, V. A.-J. (1996, Sep 15). Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation., 94(6), 1276-82. Retrieved April 19, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/8822980
Rajaie S, e. a. (2014, Jan). Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial. Nutrition., 30(1), 61-8. doi:10.1016/j.nut.2013.06.011
Sell DR, M. V. (2012). Molecular basis of arterial stiffening: role of glycation- a mini-review. Gerontology., 58(3), 227-37.
doi:10.1159/000334668
Volek JS, et al. (2004). Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women. Nutrition & Metabolism, 1(13). doi:10.1186/1743-7075-1-13
Volek JS, F. R. (2005). Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond), 2, 31. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1323303/
Forsythe CE, et al. (2008). Comparison of Low Fat and Low Carbohydrate Diets on Circulating Fatty Acid Composition and Markers of Inflammation. Lipids, 43, 65-77. doi:10.1007/s11745-007-3132-7
Jang S, et al. (28 de Jul de 2011). Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World J Gastroenterol. , 17(28), 3335-41. Recuperado el 5 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pubmed/21876622
Sasakabe T, et al. (1 de Jan de 2011). Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes. Diabetes Metab Syndr Obes., 4, 167-74.
doi:10.2147/DMSO.S19635
Adrogué HJ, et al. (2013, Nov 4). Sodium surfeit and potassium deficit: Keys to the pathogenesis of hypertension. J Am Soc Hypertens., 13, S1933-1711. doi:10.1016/j.jash.2013.09.003
Barbagallo M, et al. (2003, Feb-Jun). Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. , 24(1-3), 39-52. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/12537988 Batmanghelidj F., MD. (1997). Your Body’s Many Cries for Water. Global Health Solutions. Retrieved Feb 21, 2014, from
http://www.amazon.com/Your-Bodys-Many-Cries-Water/dp/0962994251Esposito K, et al. (2003, Apr 9). Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. , 289(14), 1799-804. Retrieved March 8, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/12684358
Field AE, et al. (2001, Jul 9). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med., 161(13), 1581-6. Retrieved March 9, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/11434789 Friedberg CE, et al. (1991, Feb). Sodium retention by insulin may depend on decreased plasma potassium. Metabolism., 40(2), 201-4. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/1988777
H. K. Caldwell & W. S. Young, III. (2014). Oxytocin and Vasopressin: Genetics and Behavioral Implications. Handbook of Neurochemistry and Molecular Neurobiology: Neuroactive Proteins and Peptides(3rd edition). Berlin: Springer. Retrieved Marzo 8, 2014, from http://refworks.springer.com/mrw/fileadmin/pdf/Neurochemistry/0387303480C25.PDF
He J, et al. (2000, Feb). Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. , 35(2), 544-9. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/10679495 Houston M. (2011, Nov). The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). , 13(11), 843-7. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/22051430
JAMA Int Med. (1997, Mar 24). Effects of Weight Loss and Sodium Reduction Intervention on Blood Pressure and Hypertension Incidence in Overweight People With High-Normal Blood Pressure. Arch Intern Med., 157(6), 657-67. Retrieved March 9, 2014, from http://archinte.jamanetwork.com/article.aspx?articleid=623090
Kannel WB. (1996). Blood Pressure as a Cardiovascular Risk Factor. JAMA., 275(20), 1571-1576. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/8622248
Kannel WB. (2000, Jan 13). Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens. , 1(2), 3S-10S. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/10678282
NIH Statistics. (2011). National Diabetes Information Clearinghouse (NDIC). Retrieved March 8, 2014, from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): http://diabetes.niddk.nih.gov/dm/pubs/statistics/#Hypertension Quiñones-Galvan A, et al. (1997, Jul-Aug). Renal effects of insulin in man. J Nephrol. , 10(4), 188-91. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/9377725
Resnick LM, et al. (1990, May). Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. Am J Hypertens., 3(5 Pt 1), 373-9. Retrieved March 8, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/2190608
Rude RK. (1989, Apr). Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency. Am J Cardiol. , 18(63), 31G-34G. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/2650512 Salonen JT, et al. (1998). Hyperinsulinemia Is Associated With the Incidence of Hypertension and Dyslipidemia in Middle- Aged Men. Diabetes February 1998, 47(2), 270-275. doi:10.2337/diab.47.2.270
Sowers JR, et al. (2001). Diabetes, Hypertension, and Cardiovascular Diseas. Hypertension., 37, 1053-1059. Retrieved March 8, 2014, from http://hyper.ahajournals.org/content/37/4/1053.abstract
Whelton SP, et al. (2002, Apr 2). Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med., 136(7), 493-503. Retrieved March 9, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/11926784 Wikipedia ATP. (2014). Trifosfato de Adenosina – ATP. Retrieved March 8, 2014, from
http://es.wikipedia.org/wiki/Adenosín_trifosfato
Yokota K, et al. (2004). Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr. , 23(5), 506S-509S. Retrieved March 8, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/15466952
Abbott C, et al. (2000, Jun). Low cholesterol and noncardiovascular mortality. Mil Med. , 165(6), 466-9. Retrieved March 9, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/10870365
Bouché C, et al. (2002, May). Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipidprofile in moderately overweight nondiabetic men. Diabetes Care., 25(5), 822-8. Retrieved April 16, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/11978675
Brescianini S, et al. (2003, Jul). Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. J Am Geriatr Soc. , 51(7), 991-6. Retrieved March 9, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/12834520
Feinman RD. (2005). When is a high fat diet not a high fat diet? Nutr Metab (Lond). , 2(27). doi:10.1186/1743-7075-2-27 Golomb BA, et al. (2005, May). Implications of statin adverse effects in the elderly. Expert Opin Drug Saf., 4(3), 389-97.
Retrieved March 9, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/15934847
Int. Diabetes Fed. (2013). About Insulin. Retrieved April 16, 2014, from http://www.idf.org/about-insulin-0
Kraft R, e. a. (2013, Jan). A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition- enhancing functions. Disease Models & Mechanisms, 6(1), 217-235. doi:10.1242/dmm.008243
Liu S, et al. (2001, Mar). Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high- density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr., 73(3), 560- 6. Retrieved April 16, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/11237932
Miller JS. (1998). Human/Pig Comparisons. Retrieved April 16, 2014, from
http://www.goshen.edu/bio/pigbook/humanpigcomparison.html
Muldoon MF, et al. (2004, Dec 1). Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med., 117(11), 823-9. Retrieved March 9, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/15589485
Ravnskov, D. U. (2009). Fat and Cholesterol are Good for You. Sweden: GB Publishing. Retrieved March 9, 2014, from
http://www.amazon.com/Fat-Cholesterol-are-Good-You/dp/919755538X
Ravnskov, U. (2002). Is atherosclerosis caused by high cholesterol? QJM: An International Journal of Medicine, 95(6), 397- 403. Retrieved March 9, 2014, from http://qjmed.oxfordjournals.org/content/95/6/397.full?ijkey=/Uh9j66HOHg.Y Schupf N, et al. (2005, Feb). Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc., 53(2), 219-26. Retrieved March 9, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/15673344 Sinitskaya N, et al. (2007, Nov). Increasing the fat-to-carbohydrate ratio in a high-fat diet prevents the development of obesity but not a prediabetic state in rats. Clin Sci (Lond). , 113(10), 417-25. Retrieved April 16, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/17608620
Uffe Ravnskov, M. P. (2003). The Retreat of the Diet-Heart Hypothesis. Journal of American Physicians and Surgeons, Volume 8 Number 3. Retrieved March 9, 2014, from http://www.jpands.org/vol8no3/ravnskov.pdf
Wiggin TD, et al. (2009, Jul). Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. , 58(7), 1634-40. Retrieved March 9, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/19411614
Willett WC, et al. (2002, Dec 30). Dietary fat is not a major determinant of body fat. Am J Med., 113(98), 47S-59S. Retrieved April 16, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/12566139
ADM. (2014). Material Safety Data Sheet – Lactic Acid. Recuperado el 8 de March de 2014, de http://www.adm.com/en- US/worldwide/australia/Documents/Lactic%20Acid%20AU.pdf
Carballo O, et al. (2014). Exfoliantes y Abrasivos. Recuperado el 8 de March de 2014, de
http://www.farmagistral.com.ar/site/files/LOS%20EXFOLIANTES%20Y%20ABRASIVOs.pdf
Hirsch IB, Brownlee M. (May-Jun de 2005). Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications., 19(3), 178-81. Obtenido de http://www.ncbi.nlm.nih.gov/pubmed/15866065 Kuwabara S, et al. (Jan de 2008). Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies. Curr Mol Pharmacol. ,1(1), 61-7. Recuperado el 8 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pubmed/20021424
Misawa S, et al. (2004). Hyperglycemia alters refractory periods in human diabetic neuropathy. Clinical Neurophysiology, 115, 2525–2529. Recuperado el 8 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/15465442
Misawa S, et al. (2005). Strength-duration properties and glycemic control in human diabetic motor nerves. Clin Neurophysiol., 116(2), 254-8. Recuperado el 8 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/15661101 Podwall D, et al. (Jan de 2004). Diabetic neuropathy: clinical features, etiology, and therapy. Curr Neurol Neurosci Rep. , 4(1),55-61. Recuperado el 8 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/14683630
Schliess F, e. a. (My-June de 2006). Cell hydration and mTOR-dependent signalling. Acta Physiol (Oxf)., 187(1-2), 223-9. Recuperado el 7 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/16734759
Schliess F. et al. (2000). Cell hydration and insulin signalling. Cell Physiol Biochem, 10(5-6), 403-8. Recuperado el 21 de Feb de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/11125222
Science Stuff. (2014). Material Safety Data Sheet – Lactic Acid. Recuperado el 8 de March de 2014, de www.sciencestuff.com: http://www.sciencestuff.com/msds/C1956.html
Smith AG, et al. (2008). Impaired glucose tolerance and neuropathy. Neurologist., 14(1), 23-9.
doi:10.1097/NRL.0b013e31815a3956
Vinik AI, et al. (2003). Diabetic Autonomic Neuropathy. Diabetes Care, 26(5), 1553-1579. doi:10.2337/diacare.26.5.155
Batmanghelidj F., MD. (1997). Your Body’s Many Cries for Water. Global Health Solutions. Retrieved Feb 21, 2014, from
http://www.amazon.com/Your-Bodys-Many-Cries-Water/dp/0962994251
Expert Review. (2013, March 1). High sugar levels found in diabetics and the obese is shown to increase risk of cancer. Expert Review of Endocrinology & Metabolism, 8(2), 101-103. doi:10.1586/eem.13.9
Hense H-W, et al. (2011). Cancer incidence in type 2 diabetes patients – first results from a feasibility study of the D2C cohort. Diabetology & Metabolic Syndrome , 3(15). doi:10.1186/1758-5996-3-15
NobelPrize.org. (2014). The Nomination Database for the Nobel Prize n Physiology or Medicine, 1901-195. Retrieved March 6, 2014, from http://www.nobelprize.org/nomination/medicine/nomination.php?action=show&showid=1089 Schliess F, e. a. (2006, My-June). Cell hydration and mTOR-dependent signalling. Acta Physiol (Oxf)., 187(1-2), 223-9.
Retrieved March 7, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/16734759
Schliess F, et al. (2000). Cell hydration and insulin signalling. Cell Physiol Biochem. , 10(5-6), 403-8. Retrieved March 7, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/11125222
ADA Pharma Financial Revenues. (2012). Revenues Received From Pharmaceutical Companies/Device Makers. American Diabetes Association. American Diabetes Association. Retrieved Feb 5, 2014, from http://adap-
old.pub30.convio.net/donate/sponsor/Pharma_Financial_Revenues_2012.pdf
ADA Position Statement. (2008, Feb). Nutrition Recommendations and Interventions for Diabetes. Diabetes Journals, 31(1), 61-78. Retrieved Feb 4, 2014, from http://care.diabetesjournals.org/content/31/Supplement_1/S61.full.pdf
ADA Research Foundation Inc. (2012). ADA Research Foundation Financial Statements 2012. American Diabetes Association Reserach Foundation Inc. Retrieved Feb 5, 2014, from
http://main.diabetes.org/dorg/PDFs/Financial/American_Diabetes_Association_Research_Foundation_2012_Financials.pd
Centers for Disease Control and Prevention. (2013). Prevalence of Overweight and Obesity Among Adults with Diagnosed Diabetes – United States, 1988–1994 and 1999–2002. Morbidity and Mortality Weekly Report (MMWR), 62(28). Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15549021
Helmchen LA, H. R. (2004, Apr). Changes in the distribution of body mass index of white US men, 1890-2000. Ann Hum Biol, 31(2), 174-81. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15204360
Lennerz B, e. a. (2013, June 26). Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutrition, 98(3), 641-647. doi:10.3945/ajcn.113.064113
Richard K. Bernstein, MD. (2007). Dr. Bernstein’s Diabetes Solution. New York: Little, Brown and Company. Retrieved from
http://www.diabetes-book.com/
Stein CJ, C. G. (2004). The Epidemic of Obesity. J Clin Endocrinol Metab, 89(6), 2522-2525. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/15181019
Belazi M, et al. (2005, May). Candida l overgrowth in diabetic patients: potential predisposing factors. Mycoses. 48(3), 192-6. Retrieved April 17, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/15842336
Britannica. (2014). Enciclopedia Britanica. Retrieved Mar 1, 2014, from Penicillium notatum:
http://www.britannica.com/EBchecked/topic/449894/Penicillium-notatum
Brown V, et al. (2006, Oct). A Glucose Sensor in Candida albicans. Eukaryotic Cell October , 5(10), 1726-1737.
doi:10.1128/EC.00186-06
Calderone RA, et al. (2001, Jul). Virulence factors of Candida albicans. Trends Microbiol. , 9(7), 327-35. Retrieved March 1, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/11435107
Crook WG, MD. (1983). The Yeast Connection. Jackson, Tennessee : Professional Books. Retrieved March 1, 2014, from
http://www.amazon.com/The-Yeast-Connection-Medical-Breakthrough/dp/0394747003
Dimorfismo, W. (2014). Dimorfismo fúngico. Retrieved March 2, 2014, from
http://es.wikipedia.org/wiki/Dimorfismo_f%C3%BAngico
Goswami R, et al. (2000, Sept). Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status. Journal of Infection, 41(2), 162–166. Retrieved March 4, 2014, from
http://www.sciencedirect.com/science/article/pii/S0163445300907230
Hube B. (2004, Aug). From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol., 7(4), 336-41. Retrieved March 1, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/15288621 Iannitti T, e. a. (2010, Dec). Therapeutical use of probiotic formulations in clinical practice. Clininal Nutrition , 29(6), 701-25.doi:10.1016/j.clnu.2010.05.004
Iruretagoyena JR, et al. (2008, Marzo). Anticuerpos anti-micelio de Candida albicans en dos pacientes de cuidados intensivos con candidiasis invasora. Rev Iberoam Micologia , 23(1), 50-53. Retrieved March 1, 2014, from
http://www.reviberoammicol.com/2006-23/050053.pdf
Kailasapathy K, et al. (2000, Feb). Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol., 78(1), 80-8. Retrieved March 1, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/10651933
M S Seelig. (1966, June). Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol Rev., 30(2), 442–459. Retrieved March 1, 2014, from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC441005/
Odds FC. (1994, Sep). Pathogenesis of Candida infections. J Am Acad Dermatol., 31(3 Pt 2), S2-5. Retrieved March 1, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/8077502
Pemán J, e. a. (2011, Mar 9). Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients. BMC Infect Dis., 11(60). doi:10.1186/1471-2334-11-60
Sudbery PE. (2011, Aug). Growth of Candida albicans hyphae. Nat Rev Microbiol. , 16(9), 737-48. doi:10.1038/nrmicro2636 Tanaka Y. (2008, Dec). Immunosuppressive mechanisms in diabetes mellitus. Nihon Rinsho. 2008 Dec;66(12):2233-7, 66(12), 2233-7. Retrieved March 1, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/19069085
Truss CO, M. (1981). The Role of Candida Albicans in Human Illness. Orthomolecular Psychiatry, 10(4), 228-238. Retrieved Mar 1, 2014, from http://www.orthomolecular.org/library/jom/1981/pdf/1981-v10n04-p228.pdf
WHO IARC . (1999). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer. Lyon, France. Retrieved March 1, 2014, from http://monographs.iarc.fr/ENG/Monographs/vol71/mono71.pdf Wikipedia. (2014). Herxheimer . Retrieved March 1, 2014, from http://es.wikipedia.org/wiki/Reacción_de_Jarisch- Herxheimer
Wikipedia Fungi. (2014). Fungi. Retrieved March 1, 2014, from http://es.wikipedia.org/wiki/Fungi
Wohlgemuth S, et al. (2010, Jan). Recent developments and perspectives in the investigation of probiotic effects. 300(1), 3- 10. Retrieved March 1, 2014, from http://www.sciencedirect.com/science/article/pii/S1438422109000794 Yemma JJ, e. a. (1994). Chemical and physiological effects of Candida albicans toxin on tissues. Cytobios., 77(310), 147-58.
Retrieved March 1, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/8020249
Accurso A, B. R. (2008). Dietary carbohydrate restriction restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond), 5, 9. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359752/
Ahmad J. et al. (2006, Aug). Inflammation, insulin resistance and carotid IMT in first degree relatives of north Indian type 2 diabetic subjects. Diabetes Res Clin Pract., 73(2), 205-10. Retrieved March 4, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/16530289
Bilic-Komarica E. et al. (2012). Effects of treatment with L-thyroxin on glucose regulation in patients with subclinical hypothyroidism. Med Arh., 66(6), 364-8. Retrieved Feb 12, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/23409511 Biondi B. (2010, Aug 8). Thyroid and Obesity: An Intriguing Relationship. doi:http://dx.doi.org/10.1210/jc.2010-1245 Brenta G. (2011, July). Why Can Insulin Resistance Be a Natural Consequence of Thyroid Dysfunction? Journal of Thyroid Research, 2011, 1-9. Retrieved Feb 12, 2014, from http://www.hindawi.com/journals/jtr/2011/152850/
Broda Barnes, MD. (1976). Hypothyroidism: The Unsuspected Illness. Toronto, Canada: Fitzhenry & Whiteside Ltd. Retrieved March 4, 2014, from http://www.amazon.com/Hypothyroidism-Unsuspected-Illness-Broda-Barnes/dp/069001029X Hak AE, e. a. (2000, Feb 15). Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. , 132(4), 270-8. Retrieved March 4, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/10681281?dopt=Abstract
Johnson JL, et al. (2002, July). Diabetes and Thyroid Disease: A Likely Combination. Diabetes Spectrum , 15(3), 140-142. doi:10.2337/diaspect.15.3.140
Kadiyala R, et al. (2010, Jul). Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract. , 64(8), 1130-9. doi:10.1111/j.1742-1241.2010.02376.x
Nakajima Y, e. a. (2012, Nov). Subclinical thyroid disease. Nihon Rinsho. , 70(11), 1865-71. Retrieved March 4, 2014, from
http://www.ncbi.nlm.nih.gov/pubmed/23214054Richard K. Bernstein, MD. (2007). Dr. Bernstein’s Diabetes Solution. New York: Little, Brown and Company. Retrieved from
http://www.diabetes-book.com/
Trigopan.com.ar. (2014). Todo sobre el Bromato de Potasio. Retrieved March 5, 2014, from www.trigopan.com.ar: http://www.trigopan.com.ar/TecdelTrigo/Pages/Fichas%20Rincon%20Panaderos/Bromato.html
Velija-Asimi Z. et al. (2007). The effects of treatment of subclinical hypothyroidism on metabolic control and hyperinsulinemia. Med Arh., 61(1), 20-1. Retrieved Feb 12, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/17582969 Vondra K, et al. (2005, Dec). Thyroid gland diseases in adult patients with diabetes mellitus. Minerva Endocrinol. , 30(4), 217- 36. Retrieved March 4, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/16319810
Weetman A P. (1997, April 19). Fortnightly review: Hypothyroidism: screening and subclinical disease. BMJ: British Medical Journal, 314(7088). Retrieved March 5, 2014, from http://www.bmj.com/content/314/7088/1175
Wikipedia Bromato. (2014). Wikipedia. Retrieved March 5, 2014, from Bromato de Potasio:
http://es.wikipedia.org/wiki/Bromato_de_potasio
Wilson GR, e. a. (2005, Oct). Subclinical thyroid disease. Am Fam Physician., 15(72 (8)), 1517-24. Retrieved March 4, 2014, from http://www.ncbi.nlm.nih.gov/pubmed/16273818
Basta G et al. (Sep de 2004). Advanced glycation end products and vascular inflammation: implications for acceleratedatherosclerosis in diabetes. Cardiovascular Research, 1;63(4), 582-92. Obtenido de
http://www.ncbi.nlm.nih.gov/pubmed/15306213
de la Monte SM, et al. (2008). Alzheimer’s Disease Is Type 3 Diabetes–Evidence Reviewed. Journal of diabetes science and technology, 2(6), 1101-1113. Recuperado el 6 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769828/
Diabetes mellitus and the risk of dementia: The Rotterdam Study. (s.f.).
Fishel MA, et al. (Oct de 2005). Hyperinsulinemia provokes synchronous increases in central inflammation and beta- amyloid in normal adults. Arch Neurol. , 62(10), 1539-44. Recuperado el 5 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pubmed/16216936
Gugliucci A. . (2000). Glicación de proteínas: rol protagónico de la hiperglicemia en las complicaciones crónicas de la diabetes mellitus. Rev Med Uruguay, 16(1), 58-75. Recuperado el 5 de March de 2014, de
http://www.smu.org.uy/publicaciones/rmu/2000v1/art9.htm
Luchsinger JA, et al. (12 de Oct de 2004). Hyperinsulinemia and risk of Alzheimer disease. Neurology., 63(7), 1187-92. Recuperado el 5 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/15477536
McNay EC, et al. (May de 2010). Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem. , 93(4), 546-53. Recuperado el 6 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pubmed/20176121
Monacelli F, et al. (June de 2013). Structural Alterations of Human Serum Albumin Caused by Glycative and Oxidative Stressors Revealed by Circular Dichroism Analysis. Int J Mol Sci. , 14(6), 10694–10709. doi:10.3390/ijms140610694 Monnier VM, et al. (Jan de 1984). Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA, 81(2), 583–587. Recuperado el 5 de March de 2014, de http://www.ncbi.nlm.nih.gov/pmc/articles/PMC344723/ NewScientist Health. (28 de Nov de 2013). Are Alzheimer’s and diabetes the same disease? Recuperado el 6 de March de 2014, de http://www.newscientist.com/article/mg22029453.400-are-Alzheimers-and-diabetes-the-same-
disease.html#.Uxh9ePldWSo
Ott A, e. a. (10 de Dec de 1999). Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. , 53(9), 1937- 42. Recuperado el 5 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/10599761
Rivera EJ, e. a. (Dec de 2005). Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine. J Alzheimers Dis., 8(3), 247-68. Recuperado el 6 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/16340083
Robert L, et al. (Apr de 2008). Rapid increase in human life expectancy: will it soon be limited by the aging of elastin? Biogerontology. , 9(2), 119-33. doi:10.1007/s10522-007-9122-6
Sobal G., e. a. (Oct de 2000). Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins, Leukotrienes and Essential Fatty Acids, 63(4), 177–186. Recuperado el 5 de March de 2014, de
http://www.sciencedirect.com/science/article/pii/S0952327800902047
Steen E, e. a. (Feb de 2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease–is this type 3 diabetes? J Alzheimers Dis. , 7(1), 63-80. Recuperado el 6 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pubmed/15750215
Vasdev S, et al. (2007). Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys. , 49(1), 48-63. Recuperado el 5 de March de 2014, de
http://www.ncbi.nlm.nih.gov/pubmed/1787333
Whitmer RA. (Sep de 2007). Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep. , 7(5), 373-80. Recuperado el 5 de March de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/17764626